NCT03911843View on ClinicalTrials.gov

Omega-3 and Vitamin D Supplements in Childhood T1D

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

omega-3 supplementation

Supplementation with Ω-3, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at a dose of 50-60 mg/kg/day for 12 months, currently underway or completed after 12 months of omega-3 administration, in 22/64 T1D children

DRUG

Vitamin D supplementation

Cholecalciferol 1000 IU/die

All Listed Sponsors
collaborator

University of Eastern Piedmont

OTHER

lead

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER

NCT03911843 - Omega-3 and Vitamin D Supplements in Childhood T1D | Biotech Hunter | Biotech Hunter